Fundraising Fox415 Capital — Full Portfolio
36 tracked investments · listed companies and verified rows first
Corflow develops diagnostic and therapeutic solutions to restore healthy microvascular blood flow in the human body, serving the cardiovascular medical device industry.
HardwareHealthtechMedical Devices
Martin(Physician Co-Founder)Rick Geoffrion(Chairman and CEO)
Co-investorsBroadview VenturesLaerdal Million Lives FundPanakes PartnersKorysMérieux Equity PartnersMonte Carlo Capital+1 more
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investorsAmed VenturesThe Capital PartnershipUnorthodox VenturesNovo HoldingsQatar Investment Authority
Boston Heart Diagnostics provides diagnostic testing and cardiovascular health characterization services for disease prevention and health improvement.
Digital HealthHealthtechMedical DevicesBoston, US
Co-investorsBain Capital VenturesKeiretsu ForumLaunchpad Venture GroupSilversmith Capital PartnersSustainVC
Cardiac Success develops a cardiac remodeling therapy and the VSling device, which is in first-in-human clinical study.
BiotechHealthtechMedical Devices
Dr. Shimon Eckhouse(Chairman & Co-Founder)David Neustadter, PhD(CTO & Founder)Boaz Manash(CEO)in
PartnerFrederik Groenewegen· led
HealthtechSanta Rosa, US
Fred Khosravi(Director)Tony Fields(Executive Officer)
BoardJames Eadie(Director)Azin Parhizgar(Executive Officer, Director)inHenry A. Plain(Director)Leo Nelson Hopkins(Director)
Co-investorsLightstone VenturesEaston CapitalMorgenthalerSante Ventures
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
PartnerFrederik Groenewegen· led
Co-investors4see VenturesPrivilège VenturesZühlke VenturesBlueOcean Ventures
Endovascular Engineering develops clot removal technologies targeting venous thromboembolism.
Medical Devices
Co-investorsNorwest Venture PartnersS3 VenturesGilde HealthcarePanakes Partners
Hilo makes a CE Class IIa-certified, FDA-cleared wearable medical device and companion app for continuous, cuffless blood pressure monitoring, using an upper-arm cuff for calibration.
Digital HealthHardwareMedical Devices
Tomas Bothe(Chief Medical Officer)in
Co-investorsKfundMolten VenturesnaturalX Health Venturesredalpine
Intact Vascular develops interventional vascular medical devices intended for use by physicians trained in interventional techniques.
BiotechHealthtechMedical DevicesWayne, US
Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)
Co-investorsH.I.G. BioHealth PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersRunway Growth CapitalNew Enterprise Associates (NEA)Vensana Capital
Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.
AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US
Amr Salahieh(Executive Officer, Director, Promoter)Pablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)
Co-investorsPage One VenturesUnorthodox VenturesThe Capital Partnership
HealthtechTewksbury, US
Lisa Mastromattei(Executive Officer)Lisa Wipperman Heine(Executive Officer)Sophia Wong(Executive Officer)Richard P. Geoffrion(Executive Officer, Director)
BoardMartien Van Osch(Director)Daniel Cole(Director)
Co-investorsQiming Venture PartnersSaints CapitalXeraya CapitalForbionOxford Bioscience Partners
R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process.
BiotechHealthtechMedical DevicesNew MaterialsMountain View, US
Kamal Ramzipoor(CTO, Founder)inChristopher M. Owens(President and Chief Executive Officer)Mahmood Razavi(Director)JeanMarie Markham(Director)
BoardFrederik Groenewegen(Director)inJohn Springer(Director)
Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension.
BiotechHardwareHealthtechMedical DevicesPalo Alto, US
Jacques Seguin(Director)in
BoardAndrew M. Weiss(Executive Officer, Director)Antoine Papiernik(Executive Officer, Director)inKazumichi Kobayashi(Director)F. Thomas Watkins(Director)Frank Litvack(Director)
Co-investorsSofinnova Partners
Spiral Genetics builds genomic data mining software for comparing large populations of whole human genomes using machine learning, aimed at enabling new diagnostics and druggable targets.
AI & Machine LearningBiotechData & InfrastructureHealthtechSeattle, US
Adina Mangubat(Founder)inJeremy Bruestle(Director)Alindrina Mangubat(Executive Officer, Director)Niranjan Shekar(Vice President Science)Rob Flickenger(Director of Engineering)
BoardRichard Jacroux(Director)
Co-investorsY CombinatorSeaChangeCP VenturesDFJEverHaüsHanmi Healthcare+7 more
TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation.
BiotechHardwareHealthtechMedical DevicesFrance, FR
Ahmed Elmouelhi(President & CEO)inEsther Gerteis(Senior VP Medical & Regulatory Affairs)inMichael Litzenburger(VP R&D)in
PartnerFrederik Groenewegen· led
Co-investorsEuropean Investment BankAndera PartnersBayern KapitalBioMedPartnersCapDecisif ManagementKarista
Endologix develops medical devices and therapies for treating vascular disease, focusing on interventions such as EVAR (endovascular aneurysm repair) procedures.
HardwareHealthtechMedical DevicesSanta Rosa, US
Michael V. Chobotov(Executive Officer)inSHARI L. O'QUINN(Executive Officer)inMichael R. Kramer(Executive Officer)KIMBERLEY ELTING(Executive Officer)CHRISTOPHER CHAVEZ(Executive Officer, Director)VIVEK K. JAYARAMAN(Executive Officer)in
Co-investorsKaiser Permanente VenturesNew Enterprise Associates (NEA)Deerfield Management CompanySR One Capital Management
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.
HealthtechMedical DevicesWayne, US
Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)
Co-investorsNew Enterprise Associates (NEA)Gilde HealthcareLightstone VenturesVensana Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ACISTArteriAAtritechCardiAQ Valve TechnologiesCardiologicCoreValveCoRRect MedicalEmbolic ProtectionEmbrella CardiovascularEssential MedicalImThera MedicalLoma Vista MedicalMicrus EndovascularMoray MedicalOVUM VenturesRebound TherapeuticsTRiCaresVascular ScienceVascular Solutions
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.